The Biomedical Research Institute of Málaga (IBIMA) is a health research institute which was created in July 2010. It arose from an agreement between the Ministry of Health of the Autonomous Government of Andalusia and the University of Málaga in which they reinforced their commitment to consolidating IBIMA as a cutting-edge biomedical centre of excellence. IBIMA is one of the more than 30 institutes accredited for healthcare research in Spain by the Carlos III Institute of Health (15 January 2015). It is a multidisciplinary research space where scientists from the worlds of academia and healthcare work to improve citizens’ health and the social and economic development of Málaga province. IBIMA's administrative agency is the Andalusian Public Foundation for Health and Biomedicine Research in Málaga (FIMABIS).
IBIMA is a multidisciplinary biomedical research space centred around the Regional University Hospital of Málaga and the Virgen de la Victoria University Hospital of Málaga along with primary care centres and the biotechnology groups of the University of Málaga.
Its objective is to promote research of excellence that is preferably translational in order to obtain results that are transferable to clinical practice and biotechnology applications.
The Institute allows for the development and strengthening of a multidisciplinary biomedical research space that contributes to providing the scientific underpinnings of the Spanish National Healthcare System’s programmes and policies. It fosters research that is preferably translational in the biomolecular, Clinical, Epidemiological and Technology areas that facilitates the transfer of scientific advances made in the prevention, diagnosis, and treatment of the most prevalent health problems on the regional, national, and international levels.
IBIMA comprises more than 50 research groups from the University of Málaga and healthcare centres in the Andalusia Public Healthcare System.
Dr. Francisco J. Tinahones MadueñoIBIMA Scientific Director
The fundamental aims and objectives to be achieved with the start-up of the ibimer are expressed in groups In five major strategic axes: institutional development, scientific excellence, training, innovation, transfer and alliances, infrastructures and financing
Develop and strengthen a multidisciplinary biomedical research space principally comprising research groups from the University of Málaga, the Regional University Hospital of Málaga, the Virgen de la Victoria University Hospital, and the Costa del Sol Hospital that contributes to providing the scientific underpinnings of the Spanish National Healthcare Systems’ programmes and policies and fostering research that is preferentially translational in the biomolecular, clinical, epidemiological, and technological areas.
IBIMA, a national and European benchmark, is a proactive and innovative organisation that strives to offer the best possible research and translation of results at all times. IBIMA seeks to become a healthcare authority of reference for citizens and healthcare professionals in the lines of the research it pursues as well as to offer a public guarantee of proper research practices in regards to quality, efficacy, efficiency, and transparency in funding.
In its quest for quality scientific research, IBIMA is based on the values of collaboration, cooperation, knowledge transfer, social responsibility, efficiency, leadership, commitment, respect, the pursuit of excellence, quality, and transparency.